Phase 2 clinical study of onapristone (ONA) in patients (pts) with uterine endometrioid adenocarcinoma (EC) expressing the activated progesterone receptor (APR(pos)).

Affiliation auteurs!!!! Error affiliation !!!!
TitrePhase 2 clinical study of onapristone (ONA) in patients (pts) with uterine endometrioid adenocarcinoma (EC) expressing the activated progesterone receptor (APR(pos)).
Type de publicationJournal Article
Year of Publication2015
AuteursBonneterre J, Leary A, Campone M, Italiano A, Sablin M-P, Floquet A, Berton-Rigaud D, Lhomme C, Lesoin A, Chocteau-Bouju D, Fabbro M, Favier L, Gladieff L, Ray-Coquard I, Bexon ASusannah, Gilles EM, Bisaha J, Zukiwski A, Cottu PH
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume33
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2015.33.15_suppl.tps5616